Skip to main content

Clinical Trials

Learn about clinical trials for new diabetes treatments, technology, and care programs that may be recruiting people with diabetes in your area.

Vertex Pharmaceuticals is recruiting for a trial researching encapsulated stem cell therapy with the potential to restore insulin-producing islet cell function in people...
Join a study investigating BMF-219, a menin inhibitor that could stimulate healthy beta cell regeneration and potentially slow diabetes progression.
Lilly’s SURMOUNT-4 trial shows that Mounjaro (tirzepatide) offers remarkable weight loss in patients with a BMI of over 30. Full SURMOUNT-3 trial results highlighted the...
This trial is investigating a new oral medication, INV-202, which is designed to improve regulation in the kidney, liver, and pancreas.
Data presented at EASD 2023 reveals orforglipron's potential in type 2 diabetes management. The new oral GLP-1 medication demonstrated significant reductions for A1C and...
People with type 1 diabetes face higher kidney risks, yet treatments approved for type 2 aren't FDA approved for them due to clinical trial gaps. The EASD 2023 panel...
A third patient with type 1 diabetes becomes insulin-independent after VX-880 stem cell treatment. Presented at the 2023 EASD conference, Vertex's early-phase trial...
Hypo-RESOLVE collaborates internationally to advance hypoglycemia understanding in diabetes. Evolving from a once-understudied concern, its Hypo-METRICS app now captures...
Tirzepatide (sold as Mounjaro) is more effective than semaglutide (Ozempic) for both blood glucose control and weight loss, according to a new analysis.
Diabetic foot ulcers are a common and costly complication for people with diabetes. ON101 is a promising new topical treatment anticipated for FDA approval in the coming...
Here are our top stories from September 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings, and more.
Oslo University conducts a global study investigating eating disorder prevention in type 1 diabetes. Join the study in the Pacific and Eastern time zones if you are...
Chronic kidney disease is a serious complication for people with diabetes. Recently approved in the U.S., Jardiance (empagliflozin) has been shown to significantly slow...
Join a study at UC San Diego investigating the potential benefits of the GLP-1 agonist semaglutide in non-alcoholic fatty liver disease (NAFLD).
Join clinical trial NCT05018585 investigating Diamyd's impact on people recently diagnosed with type 1 diabetes. The investigational drug could be a game-changer in...
Explore Vertex Pharmaceuticals’ trial l measuring the safety and effectiveness of VX-880 stem cell therapy in adults with type 1 diabetes. This trial is currently...
Explore the ACT1VATE trial on managing emotional distress in type 1 diabetes. Join a group or one-on-one virtual program to boost mental well-being and diabetes care...
Novo Nordisk's REDEFINE trials test CagriSema for weight and heart health in adults with type 2 diabetes and/or obesity. Participate and shape diabetes care.
Research shows screening children ages 2-6 best predicts childhood type 1 diabetes. Early screening also leads to more timely treatment, better outcomes, and reduced...
Uncover phase 2 clinical trial results of CagriSema, a promising diabetes treatment showing improvements in A1C, weight loss, and time in range.

Pages